Par Drugs and Chemicals Limited reported earnings results for the second quarter and six months ended September 30, 2022. For the second quarter, the company reported sales was INR 248.18 million compared to INR 195.95 million a year ago. Revenue was INR 248.34 million compared to INR 196.23 million a year ago. Net income was INR 37.25 million compared to INR 22.2 million a year ago. Basic earnings per share from continuing operations was INR 3.03 compared to INR 1.8 a year ago. Diluted earnings per share from continuing operations was INR 3.03 compared to INR 1.8 a year ago.
For the six months, sales was INR 483.25 million compared to INR 360.78 million a year ago. Revenue was INR 484.94 million compared to INR 361.43 million a year ago. Net income was INR 60.19 million compared to INR 46.76 million a year ago. Basic earnings per share from continuing operations was INR 4.89 compared to INR 3.8 a year ago. Diluted earnings per share from continuing operations was INR 4.89 compared to INR 3.8 a year ago.